The application of halloysite tubule nanoclay in drug delivery

Expert Opinion on Drug Delivery

Volumn 13, Issue 7, 2016, Pages 977-986

  Lvov, Yuri M ^a,c   DeVilliers, Melgardt M ^b   Fakhrullin, Rawil F ^c  

^a LOUISIANA TECH UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c KAZAN FEDERAL UNIVERSITY   (Russian Federation)

Author keywords

Clay nanotubes; drug sustained release; halloysite tablets; nanosafety

Indexed keywords

BONE CEMENT; COSMETIC; DENTIST RESIN; HALLOYSITE CLAY NANOTUBE; NANOTUBE; RESIN; UNCLASSIFIED DRUG; ALUMINUM SILICATE; CLAY; DELAYED RELEASE FORMULATION; POLYMER; SILICON DIOXIDE;

AEROSOL; CELL GROWTH; CLAY; COMPOSITE MATERIAL; DRUG DELIVERY SYSTEM; DRUG RELEASE; MICROCAPSULE; PHYSICAL CHEMISTRY; REVIEW; SUSTAINED DRUG RELEASE; TABLET FORMULATION; TISSUE SCAFFOLD; CHEMISTRY; DELAYED RELEASE FORMULATION; MEDICINAL CHEMISTRY;

ALUMINUM SILICATES; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; NANOTUBES; POLYMERS; SILICON DIOXIDE; TISSUE SCAFFOLDS;

EID: 84964054418     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2016.1169271     Document Type: Review

References (45)

1. V.Torchilin Multifunctional nanocarriers. Adv Drug Deliv Rev. 2006;58:1532–1555.
2. M.DeVilliers, Y.Lvov. Layer-by-layer self-assembled nanoshells for drug delivery. Adv Drug Deliv Rev. 2011;63:699–701.
3. M.Antipina, G.Sukhorukov. Remote control over guidance and release properties of composite polyelectrolyte based capsules. Adv Drug Deliv Rev. 2011;63:716–729.
4. Y.Lvov, W.Wang, L.Zhang, et al. Halloysite clay nanotubes for loading and sustained release of functional compounds. Adv Mater. 2016;28:1227–1250.•• The latest review on halloysite clay nanotubes.
5. R.Price, B.Gaber, Y.Lvov. In-vitro release characteristics of tetracycline, Khellin and nicotinamide adenine dinucleotide from halloysite; a cylindrical mineral for delivery of biologically active agents. J Microencapsulation. 2001;18:713–723.
6. H.Kelly, P.Deasy, E.Ziaka, et al. Formulation and preliminary in vivo dog studies of a novel drug delivery system for the treatment of periodontitis. Intern J Pharmaceutics. 2004;274:167–183.
7. N.Veerabadran, R.Price, Y.Lvov. Clay nanotubules for drug encapsulation and sustained release. Nano J. 2007;2:215–222.• Detail description of drug loading into the nanotube lumens.
8. N.Veerabadran, D.Mongayt, V.Torchilin, et al. Organized shells on clay nanotubes for controlled release of macromolecules. Macromol Rapid Comm. 2009;24:99–103.
9. V.Vergaro, Y.Lvov, S.Leporatti. Halloysite clay nanotubes for resveratrol delivery to cancer cells. Macromol Biosci. 2012;12:1265–1271.
10. Y.Suh, D.Kil, K.Chung, et al. Natural nanocontainer for the controlled delivery of glycerol as a moisturizing agent. J Nanosci Nanotechn. 2010;10:8687–8700.
11. M.Shamsi, K.Geckeler. The first biopolymer-wrapped non-carbon nanotubes. Nanotechnology. 2008;19:075604.
12. J.Tully, R.Yendluri, Y.Lvov. Enzyme stabilization by immobilization onto and into clay nanotubes. Biomacromolecules. 2016;17:615–621.
13. M.Dzamukova, E.Naumenko, Y.M.Lvov, et al. Enzyme-activated intracellular drug delivery with tubule clay nanoformulation. Sci Reports. 2015;5:10560–10566.
14. M.Massaro, S.Piana, C.Colletti, et al. Multicavity halloysite–amphiphilic cyclodextrin hybrids for co-delivery of natural drugs into thyroid cancer cells. J Mater Chem B. 2015;3:4074–4081.
15. M.Massaro, C.Colletti, R.Noto, et al. Pharmaceutical properties of supramolecular assembly of co-loaded cardanol/ triazole-halloysite systems. Intern J Pharmac. 2015;478:476–485.
16. M.Massaro, S.Riela, P.Lo Meo, et al. Functionalized halloysite multivalent glycocluster as a new drug delivery system. J Mater Chem B. 2014;2:7732–7738.
17. M.Massaro, R.Amorati, G.Cavallaro, et al. Direct chemical grafted curcumin on halloysite nanotubes. Colloids Surf B. 2016;140:505–513.• Interesting results on outside drug grafting.
18. G.Cavallaro, G.Lazzara, M.Massaro. Biocompatible Poly(N-isopropylacrylamide)-halloysite nanotubes for thermoresponsive curcumin release. J Phys Chem C. 2015;119:8944–8951.
19. S.Riela, M.Massaro, C.Colletti, et al. Development and characterization of co-loaded curcumin/triazole-halloysite systems and evaluation of their potential anticancer activity. Int J Pharm. 2014;475:613–623.
20. C.Dionisi, N.Hanafy, C.Nobile, et al. Halloysite clay nanotubes as carriers for curcumin: characterization and application. IEEE Transact Nanotechn. 2016;15. doi:10.1109/TNANO.2016.2524072.
21. W.O.Yah, H.Xu, H.Soejima, et al. Biomimetic dopamine derivative for selective polymer modification of halloysite nanotube lumen. J Am Chem Soc. 2012;134:12134–12137.
22. H.Lun, J.Ouyang, H.Yang. Natural halloysite nanotubes modified as an aspirin carrier. RSC Adv. 2014;4:44197–44202.
23. Y.Shi, Z.Tian, Y.Zhang, et al. Functionalized halloysite nanotube-based carrier for intracellular delivery of antisense oligonucleotides. Nanoscale Res Lett. 2011;6:608–615.
24. Y.Lee, G.Jung, S.Cho, et al. Cellular interactions of doxorubicin-loaded DNA-modified halloysite nanotubes. Nanoscale. 2013;5:8577–8584.• Pioneering work on DNA-halloysite delivery.
25. D.Tan, P.Yuan, F.Annabi-Bergaya, et al. Loading and in vitro release of ibuprofen in tubular halloysite. Appl Clay Sci. 2014;96:50–55.
26. S.Strydom, D.Otto, W.Liebenberg, et al. Preparation and characterization of directly compactible layer-by-layer nanocoated cellulose. Intern J Pharmaceut. 2011;404:57–65.
27. A.Marais, M.Song, M.De Villiers. Effect of compression force, humidity and disintegrant concentration on the disintegration and dissolution of directly compressed furosemide tablets using croscarmellose sodium as disintegrant. Tropical J Pharmaceut Res. 2003;2:125–135.
28. M.Song, N.Li, S.Sun, et al. Effect of viscosity and concentration of wall former, emulsifier and pore-inducer on the properties of amoxicillin microcapsules prepared by emulsion solvent evaporation. Il Farmaco. 2005;60:261–267.
29. J.De Kruif, G.Ledergerber, C.Garofalo, et al. On prilled nanotubes-in-microgel oral systems for protein delivery. Eur J Pharmaceut Biopharmaceut. 2016;101:90–102.
30. Y.Zhang, R.Gao, M.Liu, et al. Use of modified halloysite nanotubes in the feed reduces the toxic effects of zearalenone on sow reproduction piglet development. Theriogenology. 2014;12:1–9.
31. M.Liu, C.Wu, Y.Jiao, et al. Chitosan–halloysite nanotubes nanocomposite scaffolds for tissue engineering. J Mater Chem B. 2013;1:2078–2089.
32. E.Naumenko, I.Guryanov, R.Yendluri, et al. Clay nanotube - biopolymer composite scaffolds for tissue engineering. Nanoscale. 2016;8. doi:10.1039/C6NR00641H.• Testing of halloysite scaffolds implanted in rats.
33. J.Xue, M.He, H.Liu, et al. Drug loaded homogeneous electrospun PCL/gelatin hybrid nanofiber structures for anti-infective tissue regeneration membranes. Biomaterials. 2014;35:9395–9405.
34. J.Hue, Y.Niu, M.Gong, et al. Antimicrobial tissue with prolonged drug release produced with electrospinning of clay nanotubes/gelatin composites. ACS Nano. 2015;9:1600–1608.• Representative paper on electrospun halloysite tissue with extended drug release.
35. W.Wei, E.Abdullayev, A.Hollister, et al. Clay nanotube/poly(methylmethacrylate) bone cement composite with sustained antibiotic release. Macromolec Mater Engin. 2012;297:645–653.
36. D.Mills, Y.Lvov. Ceramic nanotube composites with sustained drug release capability for implants, bone repair and regeneration. Patent US9192912. 2015 Nov 24.
37. S.Feitosa, E.Münchow, A.Al-Zain, et al. Synthesis and characterization of novel halloysite-incorporated adhesive resins. J Dent. 2015;43:1316–1322.
38. M.Alkatheeri, J.Palasuk, G.Eckert, et al. Halloysite nanotube incorporation into adhesive systems - effect on bond strength to human dentin. Clin Oral Investig. 2015;19:1905–1912.
39. W.Wei, R.Minullina, R.Fakhrullin, et al. Enhanced efficiency of antiseptics with sustained release from clay nanotubes. RCS Adv. 2014;4:488–495.
40. E.Abdullayev, K.Sakakibara, K.Okamoto, et al. Natural tubule clay template synthesis of silver nanorods for antibacterial coating. ACS Appl Mater Interf. 2011;3:4040–4048.
41. V.Vergaro, E.Abdullayev, Y.Lvov, et al. Cytocompatibility and uptake of halloysite clay nanotubes. Biomacromol. 2010;11:820–826.
42. X.Lai, M.Agarwal, Y.Lvov, et al. Proteomic profiling of halloysite clay nanotube exposure in intestinal cell co-culture. J Appl Toxicity. 2013;33:1316–1329.
43. F.Ahmed, M.Shoaib, M.Azharc, et al. In-vitro assessment of cytotoxicity of halloysite nanotubes against HepG2, HCT116 and human peripheral blood lymphocytes. Colloids Surf B Biointerfaces. 2015;135:50–55.
44. G.Fakhrullina, F.Akhatova, Y.Lvov. Toxicity of halloysite clay nanotubes in vivo: a Caenorhabditis elegans study. Environ Sci Nano. 2015;2:54–59.• Important paper on microorganism toxicity of halloysite.
45. M.Kruchkova, Y.Lvov, R.Fakhrullin. In vivo toxicity of nanoclays and graphene oxide: a paramecium caudatum study. Environ Sci Nano. 2016;3. doi:10.1039/C5EN00201J.